Active ingredient
OCRELIZUMAB
Registration activity, product holders, and manufacturers linked to this active ingredient in the AIPHARM dataset.
Registered products
1
Top manufacturer
F. HOFFMANN-LA ROCHE AG
Top holder
ROCHE (MALAYSIA) SDN. BHD.
Updated
23 May 2026
Overview
Product registrations over time
Latest visible period: 2023
Analysis
Companies connected to this ingredient
Analysis
Product Manufacturer
| Manufacturer name | Product count |
|---|---|
| 1 |
Product count1
Rows per page:
1–1 of 1
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 1 |
Product count1
Rows per page:
1–1 of 1
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| OCREVUS 300mg/10mL Concentrate for Solution for Infusion | MAL23116001ARZ | BIOLOGICS | ROCHE (MALAYSIA) SDN. BHD. | F. HOFFMANN-LA ROCHE AG | ROCHE (MALAYSIA) SDN. BHD. | PRODUCT APPROVED |
OCREVUS 300mg/10mL Concentrate for Solution for Infusion
Product Reg. noMAL23116001ARZ
TypeBIOLOGICS
Product HolderROCHE (MALAYSIA) SDN. BHD.
ManufacturerF. HOFFMANN-LA ROCHE AG
ImporterROCHE (MALAYSIA) SDN. BHD.
Registration StatusPRODUCT APPROVED
Rows per page:
1–1 of 1